Portal mesenteric vein thrombosis - As mentioned in previous discharge summary, the patient was managed conservatively in the unit with intravenous antibiotics which were discontinued on the day of transfer to the floor, [**2146-4-19**], heparin drip with transition to Warfarin, serial abdominal examinations.
At the time of discharge, the patient was therapeutic on Warfarin for over 48 hours and heparin had been discontinued.
A hypercoagulability workup was also initiated with Cardiolipin and Beta 2 glycoprotein antibodies which were negative.
[**Name10 (NameIs) **] patient will also require screening for metastatic disease as a possible cause for hypercoagulability including mammogram and colonoscopy as an outpatient.
At the time of discharge, the patient's abdominal pain had nearly completely resolved and she was tolerating a solid diet without difficulty.
The patient will be continued on Loperamide as an outpatient.
The patient was continued on Metoprolol, Lasix, and ACE inhibitor, (transitioned to Lisinopril), which were titrated up as tolerated.
However, given that her blood pressure was stable and in order to achieve maximal control of her congestive heart failure, the patient was started on Metoprolol and an ACE inhibitor as well as Lasix.
The patient's blood pressure remained stable and these medications were titrated up prior to discharge.
The patient had a cholesterol panel which did not suggest that she require a statin at this time, however, follow up panel when she has had a more sustained period of adequate p.o.
Given the patient's history of guaiac positive stool and the fact that she is currently anticoagulated, an aspirin was not given.
She will require period hematocrit check as an outpatient in order to ensure adequate iron replacements.
Outpatient esophagogastroduodenoscopy and colonoscopy for evaluation of iron deficiency and guaiac positive stools.
The patient will require monitoring of her INR twice a week and adjustment of her Coumadin as necessary for an INR of 2 to 3.
The patient will require monitoring of her pulmonary status including oxygen saturation; and may need to adjust diuretics (Lasix) as needed.
The patient will require physical therapy three to five times a week to increase strength, endurance and mobility.
Lantanaprost .005% one drop both eyes q.h.s.
Acetaminophen 325 to 650 mg p.o.
Zolpidem 5 mg p.o.
Trazodone 25 mg p.o.
Iron sulfate 325 mg p.o.
Ascorbic acid 500 mg p.o.
Albuterol metered dose inhaler 1 to 2 puffs q.
Atrovent 18 mcg aerosol metered dose inhaler 2 puffs q.i.d.
Lansoprazole 30 mg p.o.
Lisinopril 10 mg p.o.
Loperamide 2 mg p.o.
Lasix 40 mg p.o.
Oxycodone 5 to 10 mg p.o.
Lorazepam .5 mg p.o.
4-6 hours prn anxiety.
Toprol XL 50 mg p.o.
Coumadin 2.5 mg p.o.
Promethazine 12.5 mg intravenously q.
6 hours prn nausea.
